- Home
- NOTV vs FORA Comparison
NOTV vs FORA Comparison
Compare NOTV & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- FORA
- Stock Information
- Founded
- NOTV 1974
- FORA 2014
- Country
- NOTV United States
- FORA United States
- Employees
- NOTV N/A
- FORA N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- NOTV Health Care
- FORA Technology
- Exchange
- NOTV Nasdaq
- FORA Nasdaq
- Market Cap
- NOTV 62.5M
- FORA 66.1M
- IPO Year
- NOTV 1997
- FORA N/A
- Fundamental
- Price
- NOTV $2.00
- FORA $2.05
- Analyst Decision
- NOTV Strong Buy
- FORA Strong Buy
- Analyst Count
- NOTV 1
- FORA 1
- Target Price
- NOTV $5.00
- FORA $5.00
- AVG Volume (30 Days)
- NOTV 512.6K
- FORA 7.5K
- Earning Date
- NOTV 08-07-2025
- FORA 08-13-2025
- Dividend Yield
- NOTV N/A
- FORA N/A
- EPS Growth
- NOTV N/A
- FORA N/A
- EPS
- NOTV N/A
- FORA N/A
- Revenue
- NOTV $480,402,000.00
- FORA $22,332,001.00
- Revenue This Year
- NOTV $4.99
- FORA $46.25
- Revenue Next Year
- NOTV $5.39
- FORA $11.30
- P/E Ratio
- NOTV N/A
- FORA N/A
- Revenue Growth
- NOTV N/A
- FORA 5.22
- 52 Week Low
- NOTV $1.15
- FORA $1.85
- 52 Week High
- NOTV $6.48
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- NOTV 49.04
- FORA 49.88
- Support Level
- NOTV $2.06
- FORA $1.96
- Resistance Level
- NOTV $2.30
- FORA $2.21
- Average True Range (ATR)
- NOTV 0.17
- FORA 0.12
- MACD
- NOTV 0.02
- FORA 0.00
- Stochastic Oscillator
- NOTV 70.31
- FORA 33.33
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.